Our Team Blue Sky just completed a fascinating session targeting 2045—a timeline that reveals how biotech convergence with AI and engineering will reshape not just medicine, but the entire economic landscape. While equity analysts focus on obvious trends like CRISPR and mRNA platforms, our viewers detected patterns that suggest the real transformation is already underway.
This isn't about predicting the next biotech stock pick. It's about understanding the structural shifts that will create entirely new categories of wealth and the underground developments that mainstream media won't cover for years.
This session was recorded on December 22, 2025.